Pages that link to "Q24561905"
Jump to navigation
Jump to search
The following pages link to Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies (Q24561905):
Displaying 50 items.
- Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10 (Q21089590) (← links)
- CCR5 monoclonal antibodies for HIV-1 therapy (Q22242739) (← links)
- Antibody vs. HIV in a clash of evolutionary titans (Q24536059) (← links)
- bNAber: database of broadly neutralizing HIV antibodies (Q24567758) (← links)
- Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals (Q24635002) (← links)
- Neutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitors (Q24655129) (← links)
- Catalytic antibodies to HIV: physiological role and potential clinical utility (Q24655912) (← links)
- A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) (← links)
- Antibody responses to envelope glycoproteins in HIV-1 infection (Q26991572) (← links)
- HIV-1 neutralizing antibodies: understanding nature's pathways (Q27000480) (← links)
- HIV broadly neutralizing antibody targets (Q27026662) (← links)
- Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells (Q27320687) (← links)
- A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies (Q27485578) (← links)
- Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates (Q27489000) (← links)
- Antibodies against viruses: passive and active immunization (Q27489392) (← links)
- Structure of Antibody F425-B4e8 in Complex with a V3 Peptide Reveals a New Binding Mode for HIV-1 Neutralization (Q27649247) (← links)
- A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120 (Q27649541) (← links)
- Structure determination of an anti-HIV-1 Fab 447-52D–peptide complex from an epitaxially twinned data set (Q27650903) (← links)
- A Conformational Switch in Human Immunodeficiency Virus gp41 Revealed by the Structures of Overlapping Epitopes Recognized by Neutralizing Antibodies (Q27655865) (← links)
- Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications (Q27657377) (← links)
- Crystal structure of a 3B3 variantâ A broadly neutralizing HIV-1 scFv antibody (Q27657585) (← links)
- Interactions between Lipids and Human Anti-HIV Antibody 4E10 Can Be Reduced without Ablating Neutralizing Activity (Q27658138) (← links)
- Structural Basis of the Cross-Reactivity of Genetically Related Human Anti-HIV-1 mAbs: Implications for Design of V3-Based Immunogens (Q27658173) (← links)
- Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction (Q27661588) (← links)
- Conserved structural elements in the V3 crown of HIV-1 gp120 (Q27663325) (← links)
- Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope (Q27664365) (← links)
- Elicitation of structure-specific antibodies by epitope scaffolds (Q27664711) (← links)
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield (Q27675032) (← links)
- Human Anti-V3 HIV-1 Monoclonal Antibodies Encoded by the VH5-51/VL Lambda Genes Define a Conserved Antigenic Structure (Q27676155) (← links)
- Autoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10 (Q27680125) (← links)
- Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 Epitope (Q27681352) (← links)
- Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization (Q27684578) (← links)
- Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design (Q28075274) (← links)
- The good and evil of complement activation in HIV-1 infection (Q28275986) (← links)
- Insensitivity of paediatric HIV-1 subtype C viruses to broadly neutralising monoclonal antibodies raised against subtype B (Q28469023) (← links)
- Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India (Q28483205) (← links)
- Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene (Q28554907) (← links)
- Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies (Q28602877) (← links)
- A directed molecular evolution approach to improved immunogenicity of the HIV-1 envelope glycoprotein (Q28743092) (← links)
- Anti-V3 monoclonal antibodies display broad neutralizing activities against multiple HIV-1 subtypes (Q28752503) (← links)
- Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope (Q29307502) (← links)
- Broad neutralization coverage of HIV by multiple highly potent antibodies (Q29615361) (← links)
- Distribution and three-dimensional structure of AIDS virus envelope spikes (Q29617562) (← links)
- Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies (Q29619015) (← links)
- Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 (Q29619511) (← links)
- Passive immunization against HIV/AIDS by antibody gene transfer. (Q30358434) (← links)
- The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. (Q30367176) (← links)
- Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. (Q30369026) (← links)
- Appreciating HIV type 1 diversity: subtype differences in Env. (Q30375834) (← links)
- Construction and Phenotypic Characterization of HIV Type 1 Functional Envelope Clones of Subtypes G and F (Q30398490) (← links)